510(k) Report

FDA applicant

Stx-Med Sprl

Herstal, Liege, BE1 decision2014–20140 recalls

FDA records 1 decision for Stx-Med Sprl (Herstal, Liege, BE) in 2014: 1 De Novo grant. All are in product code PCC (Stimulator, Nerve, Electrical, Transcutaneous…). No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, neurology panel, where it files most

How often FDA has decided Stx-Med Sprl’s devices, and how often a recall has named them.

FDA decisions per year

1in 2014

2014: 1
2014high 1 (2014) · low 0 (2015)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2014.

FIG. 1 — Stx-Med Sprl by year, 2014–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Stx-Med Sprl’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Which product codes does it file in?

  • PCCStimulator, Nerve, Electrical, Transcutaneous, For Migraine1decision

Who builds on its devices?

Later devices cite its devices 2 times; 0 of those are its own. The firms that cite it most:

Which of its devices are cited most?

Its devices that later submissions most often claim equivalence to.

What has FDA decided for it lately?

The one decision as Stx-Med Sprl →